Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
about
Screening for prostate cancerProstate cancer screening in Brazil: should it be done or not?Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial.Transperineal prostate biopsies for diagnosis of prostate cancer are well tolerated: a prospective study using patient-reported outcome measures.The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer.Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT studyComplications of initial prostate biopsy in a European randomized screening trialCombination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia.Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.Radical prostatectomy versus observation for localized prostate cancer.Evaluation of neutrophil-to-lymphocyte ratio prior to prostate biopsy to predict biopsy histology: Results of 1836 patients.Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies.The detection and upgrade rates of prostate adenocarcinoma following transperineal template-guided prostate biopsy - a tertiary referral centre experience.Five-year downstream outcomes following prostate-specific antigen screening in older menApplications of transrectal ultrasound in prostate cancer.Knowledge and practice of prostate cancer screening among general practitioners in Malaysia: a cross-sectional study.Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial.Risk of hospitalization and death following prostate biopsy in Scotland.Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.Prevention and treatment of biopsy-related complications.Optimization of prostate biopsy: review of technique and complications.Incidence of needle-tract seeding following prostate biopsy for suspected cancer: a review of the literature.Prostate-specific antigen screening, why have the guidelines changed?Focal cryotherapy of localized prostate cancer: a systematic review of the literature.Transperineal template-guided mapping biopsy of the prostate.The psychological impact of prostate biopsy: prevalence and predictors of procedure-related distress.Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening.N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.Morbidity and psychological impact of prostate biopsy: the future calls for a change.The association of level of practical experience in transrectal ultrasonography guided prostate biopsy with its diagnostic outcome.A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance.Prospective evaluation of the safety of transrectal ultrasound-guided transperineal prostate biopsy based on adverse events.Prostate-specific antigen testing in men between 40 and 70 years in Brazil: database from a check-up program.Factors associated with current and severe physical side-effects after prostate cancer treatment: What men report.Hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England.Prostatic biopsy-related rectal bleeding refractory to medical and endoscopic therapy definitively managed by catheter-directed embolotherapy: a case report.A urine-based methylation signature for risk stratification within low-risk prostate cancer.Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.Histologic variability and diverse oncologic outcomes of prostate sarcomas.
P2860
Q24201690-84FE1ED3-F76D-421A-9F53-812E8CE1F808Q28068688-2605C9A5-C767-405E-A8AB-F655B29F678EQ30625083-7C57C1C5-6588-4526-96CB-C240F8EE9FF7Q33166857-BCE3F1E6-061C-4184-BFFE-1E4BFDA7B1F8Q33922385-2DBD30C9-CB82-43A0-87CF-DBB48376FE06Q33927384-C9B21656-5EAC-4A3B-A507-A65F77981B43Q34448107-85667F21-13D0-45D7-B6E5-3E84759483D0Q35651467-DA512DA0-D9D1-43FA-95C0-26ABF5388B54Q36111875-6BA9560B-1E74-4AE8-8E34-7CA33C444FE4Q36194308-3FA6259F-DF4C-4E9F-9A8B-990220B30691Q36264770-765D01FE-1286-4380-8C90-F2A3CA46CAEAQ36336025-077A56EF-1D8A-49EF-82B3-694DCF8A9B30Q36840690-D5C59ABF-BB14-4D30-85B6-921E53B540BCQ37017183-1D3B4F46-812D-4E97-AF55-44A93FC35767Q37102542-0C8A5495-31B5-4840-A725-08C71858E1DBQ37312608-76CE9902-9BA8-42DD-85A7-DAE9DE4C07F6Q37395990-1D4D8D28-75A7-4D5A-BAB0-07D5A84D4377Q37415257-9250B580-E123-4E9C-8BBC-C2320D79818FQ37579726-8BF144A3-4E4B-4E9E-91E5-EFC80ED785DCQ37716322-1EDBC87A-4691-46F6-8D62-65E86CC3405BQ38175326-3992AC2C-F611-441B-A1B0-62984F3F554EQ38203986-2345A965-1A6A-4DE4-9257-3D37B2A12AE0Q38222664-705FE8B4-BE9F-4C94-9383-DDA96BEF7BCEQ38259244-19E48E46-7AE6-4447-BF34-D056A715B907Q38264786-5037DF57-BF14-4A8C-9563-7CC0EE8BD17CQ38271115-D35893E3-AFFF-48DC-A5B7-5717A89679B4Q38647436-E2EF9A70-832D-4223-B3E2-72559541D3F6Q38668005-89C85BBA-AE52-4773-B197-06EE20CF3D3BQ39062377-0986731A-96B5-473B-8EF6-B687363DF830Q39213491-14A0400C-6D09-4A86-A478-6DA877F091DAQ39360687-2FECDEFD-F26F-4501-9BFC-26F93DC4EC9AQ40115001-FC077D0B-FBEA-4F51-840D-E3D6D8CBA884Q40158523-44DEF97E-C2D6-438B-824A-4D22C5503902Q40251884-52A368A8-01B6-4D50-9683-303D847AB4DEQ40547127-8B8C99CA-A409-42C6-B3BA-23A8FA18C3E7Q41725663-6FE5EC4D-C786-41BE-8CC7-D66E2FB03DE8Q42029873-5F2FE107-1049-46FA-9191-4597C84CFE31Q42121326-DC50EDD4-D94B-4C9E-AF0A-78987FB61FBBQ42558314-EF7815C2-1C8E-43BA-A8F2-BAAE4BF27369Q42614042-19A20DBE-5A66-402D-8700-FD1634047C34
P2860
Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Short term outcomes of prostat ...... aluation within ProtecT study.
@ast
Short term outcomes of prostat ...... aluation within ProtecT study.
@en
type
label
Short term outcomes of prostat ...... aluation within ProtecT study.
@ast
Short term outcomes of prostat ...... aluation within ProtecT study.
@en
prefLabel
Short term outcomes of prostat ...... aluation within ProtecT study.
@ast
Short term outcomes of prostat ...... aluation within ProtecT study.
@en
P2093
P2860
P50
P356
P1433
P1476
Short term outcomes of prostat ...... valuation within ProtecT study
@en
P2093
Andy Doble
Derek J Rosario
Freddie C Hamdy
J Athene Lane
Jenny L Donovan
Kerry Avery
Louise Goodwin
Michael Davis
P2860
P356
10.1136/BMJ.D7894
P407
P577
2012-01-09T00:00:00Z